View Older Stories View More Recent Stories

Jul 14, 2022 04:10PM Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Jul 14, 2022 04:00AM Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
Jul 13, 2022 09:25AM Pre-Open Movers: ironSource Surges on Buyback, Tech Stocks Fall on Hot CPI
Jun 28, 2022 04:00AM Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
Jun 22, 2022 06:02AM Illumina (ILMN) Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Jun 22, 2022 06:00AM Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Jun 9, 2022 04:08PM Illumina (ILMN) Announces Joydeep Goswami Appointed Interim CFO; Sam Samad To Depart
Jun 9, 2022 04:05PM JOYDEEP GOSWAMI APPOINTED INTERIM CFO; SAM SAMAD TO DEPART ILLUMINA
Jun 7, 2022 09:15AM Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
Jun 2, 2022 01:10PM Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO
May 31, 2022 09:02AM GRAIL (ILMN) Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
May 31, 2022 09:00AM GRAIL Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
May 24, 2022 08:30AM Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
May 24, 2022 05:50AM Illumina (ILMN) Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
May 24, 2022 02:00AM Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
May 18, 2022 09:15AM Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
May 5, 2022 04:05PM Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
May 5, 2022 09:15AM Illumina (ILMN) Partners with Deerfield Management to Accelerate Drug Development
May 5, 2022 09:15AM Illumina and Deerfield Management partner to accelerate drug development
Apr 28, 2022 04:05PM Illumina To Webcast Upcoming Investor Conference
Apr 25, 2022 02:00AM Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
Apr 19, 2022 12:00PM PGA TOUR Champions and GRAIL Announce The Galleri® Classic
Apr 14, 2022 04:05PM Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
Apr 12, 2022 08:00AM Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center
Apr 11, 2022 10:29AM John Frank Joins Illumina as Chief Public Affairs Officer
Apr 7, 2022 11:00AM Illumina Releases Annual Corporate Social Responsibility Report
Apr 5, 2022 08:00AM DNA Data Storage Alliance Welcomes 50th Member
Mar 16, 2022 09:15AM Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
Mar 15, 2022 05:50AM Illumina (ILMN) Unveils Comprehensive Genomic Profiling Test for Cancer in Europe
Mar 15, 2022 03:00AM Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
Mar 14, 2022 09:15AM Illumina (ILMN) Appoints Carissa Rollins as Chief Information Officer
Mar 14, 2022 09:15AM Illumina Welcomes Carissa Rollins as Chief Information Officer
Feb 21, 2022 04:05PM Illumina To Webcast Upcoming Investor Conference
Feb 10, 2022 04:05PM Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
Feb 3, 2022 04:05PM Illumina To Webcast Upcoming Investor Conferences
Feb 3, 2022 05:43AM Illumina (ILMN) Enters Partnerships in France for Precision Medicine Approach to Late-Stage Cancer
Feb 3, 2022 01:00AM Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
Jan 24, 2022 08:30AM Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
Jan 20, 2022 04:05PM Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022
Jan 10, 2022 04:21PM Illumina collaborates with Nashville Biosciences to accelerate medicines development
Jan 10, 2022 04:20PM Illumina (ILMN) announces preliminary consolidated fourth quarter revenue of approximately $1.19 billion
Jan 10, 2022 04:19PM Illumina (ILMN) Enters Partnership with Boehringer Ingelheim for Diagnostic Programs
Jan 10, 2022 04:19PM Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
Jan 10, 2022 04:17PM Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
Jan 10, 2022 04:15PM Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference
Jan 10, 2022 08:15AM GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
Jan 5, 2022 04:15PM Illumina Enters Co-Development Partnership with SomaLogic
Jan 5, 2022 04:14PM Somalogic (SLGC) announces exclusive partnership with Illumina (ILMN) to develop sequencing-based proteomic solutions
Dec 23, 2021 04:05PM Illumina To Webcast Upcoming Investor Conference
Dec 20, 2021 07:05AM Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
View More Recent Stories View Older Stories